Divergent Outcomes in Lung Adenocarcinoma with Paraneoplastic Hypereosinophilia in Patients Treated with Pembrolizumab: A Two-Case Report
International Medical Case Reports Journal · 2026-07 · Volume 19 · 1-6
DOI: 10.2147/imcrj.s550027 ↗Kurz gefasst
Fallbericht in der Zeitschrift International Medical Case Reports Journal, 2026-07. Verfasst von Akash Oza und 2 weiteren Autor:innen. Beteiligte Einrichtung: Section of General Internal Medicine, Department of Medicine, Boston University School of Medicine, Boston, MA, USA. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Section of General Internal Medicine, Department of Medicine, Boston University School of Medicine, Boston, MA, USA.
- The Pulmonary Center, Department of Medicine, Boston University School of Medicine, Boston, MA, USA.
Zitieren
APA
Oza, A., Stickler, M. B., & Little, F. F. (2026). Divergent Outcomes in Lung Adenocarcinoma with Paraneoplastic Hypereosinophilia in Patients Treated with Pembrolizumab: A Two-Case Report. International Medical Case Reports Journal, Volume 19, 1-6. https://doi.org/10.2147/imcrj.s550027
Vancouver
Oza A, Stickler MB, Little FF. Divergent Outcomes in Lung Adenocarcinoma with Paraneoplastic Hypereosinophilia in Patients Treated with Pembrolizumab: A Two-Case Report. International Medical Case Reports Journal. 2026;Volume 19:1-6. doi:10.2147/imcrj.s550027
BibTeX
@article{Oza2026,
author = {Oza, Akash and Stickler, Michelle B and Little, Frederic F},
title = {Divergent Outcomes in Lung Adenocarcinoma with Paraneoplastic Hypereosinophilia in Patients Treated with Pembrolizumab: A Two-Case Report},
journal = {International Medical Case Reports Journal},
year = {2026},
volume = {Volume 19},
pages = {1--6},
doi = {10.2147/imcrj.s550027}
}
EUVIMED